The proposed amendments to Section 26-1-3.2 NMSA 1978, notably, allow donations from a wider pool, including individuals from outside the state, and set standards for handling and redistributing these drugs. This increases the potential reach of the program, potentially benefiting more patients while adhering to strict safety standards. The bill emphasizes compliance with public health regulations and prohibits the redistribution of controlled substances, aiming to maintain safety in drug distribution.
Summary
Senate Bill 34 aims to expand the prescription drug donation program in the state of New Mexico by allowing a broader range of donors and recipients to participate. The bill provides mechanisms for individuals and entities, including healthcare facilities, to donate unused, unexpired prescription drugs to designated eligible recipients. The goal is to ensure that donated medications can be redistributed safely and effectively to patients who need them, thereby enhancing access to medications and reducing waste.
Contention
Some points of contention surrounding SB34 could revolve around the liability protections it offers to donors and recipients. The bill includes provisions that grant immunity from civil or criminal liability for individuals and organizations that participate in the donation process, provided they exercise reasonable care. This aspect of the bill may raise concerns regarding accountability in cases where patients experience adverse effects from received medications, although supporters argue that such protections are necessary to encourage participation in the program.
An Act amending the act of May 13, 2008 (P.L.139, No.14), known as the Cancer Drug Repository Program Act, further providing for title and short title of act, for definitions, for establishment, for r . . .estocking and dispensing of cancer drugs, for storage, distribution and fees and for immunity; providing for annual report, for list of approved participating pharmacies and for limitations; further providing for regulations; and imposing duties on the State Board of Pharmacy.